MediWound vs SignalChem Lifesciences Corporation (SLC)

MediWound logo

MediWound

The global leader in next-generation enzymatic therapeutics focused on non-surgical tissue repair

110 employees · est. 2000 · Yavne, Israel

VS
SignalChem Lifesciences Corporation (SLC) logo

SignalChem Lifesciences Corporation (SLC)

Drug discovery focused on developing novel small molecule kinase inhibitors for the treatment of cancer

14 employees · est. 2012 · Richmond, Canada

MediWound is the older company (2000 vs 2012); MediWound is the larger of the two.

Side-by-Side Comparison

MediWound SignalChem Lifesciences Corporation (SLC)
Founded
2000 older 2012
Headquarters
Yavne, Israel Richmond, Canada
Employees
110 larger 14
Industry
Biotechnology, Manufacturing, Medical Devices Life Sciences, Pharmaceutical
Funding Stage
Post-IPO Equity Not tracked yet
Total Funding
$152.65M Not tracked yet
Funding Rounds
10 Not tracked yet
Taxonomy
Enzymatic TherapeuticsTissue RepairBurns TreatmentWound ManagementBiologics DevelopmentFDA-approved Drugs +7 Drug DiscoveryBioreagentsKinase InhibitorsCancer TreatmentClinical DevelopmentSmall Molecule Drugs +8
Website
mediwound.com signalchemlifesciences.com
MediWound logo

About MediWound

MediWound Ltd. (Nasdaq: MDWD) is a leading player in the field of next-generation enzymatic therapeutics, with a focus on non-surgical tissue repair. The company's flagship product, NexoBrid®, has garnered FDA approval as an orphan biologic for eschar removal in severe burns, offering a compelling a...

SignalChem Lifesciences Corporation (SLC) logo

About SignalChem Lifesciences Corporation (SLC)

SignalChem Lifesciences is a pharmaceutical startup headquartered in British Columbia, Canada. Established in 2004, the company has quickly emerged as a global leader in cell signaling and protein engineering, focusing on developing novel small molecule kinase inhibitors for the treatment of cancer....

Also comparing in this category

We will tell you when either one moves

BounceWatch watches MediWound and SignalChem Lifesciences Corporation (SLC) for new funding, fast hiring, new executives and a change of software vendor. When one happens, it is in your next e-mail.

Get notified when MediWound or SignalChem Lifesciences Corporation (SLC) moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

Frequently Asked Questions

MediWound was founded in 2000, based in Yavne, Israel, with 110 employees. MediWound Ltd. (Nasdaq: MDWD) is a leading player in the field of next-generation enzymatic therapeutics, with a focus on non-surgical tissue repair. The company's flagship product, NexoBrid®, has gar. SignalChem Lifesciences Corporation (SLC) was founded in 2012, based in Richmond, Canada, with 14 employees. SignalChem Lifesciences is a pharmaceutical startup headquartered in British Columbia, Canada. Established in 2004, the company has quickly emerged as a global leader in cell signaling and protein eng.
MediWound has raised $152.65M and SignalChem Lifesciences Corporation (SLC) no disclosed funding. Latest stage: MediWound Post-IPO Equity.
Both list clinical development among their focus areas.

Compare MediWound with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at MediWound on 12 Sep 2024, and SignalChem Lifesciences Corporation (SLC) on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes